• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Grand Challenges in Ocular Inflammatory Diseases.

作者信息

Xu Heping, Rao Narsing A

机构信息

The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom.

Aier Institute of Optometry and Vision Science, Changsha, China.

出版信息

Front Ophthalmol (Lausanne). 2022 Feb 17;2:756689. doi: 10.3389/fopht.2022.756689. eCollection 2022.

DOI:10.3389/fopht.2022.756689
PMID:38983535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11182270/
Abstract
摘要

相似文献

1
Grand Challenges in Ocular Inflammatory Diseases.眼部炎性疾病的重大挑战
Front Ophthalmol (Lausanne). 2022 Feb 17;2:756689. doi: 10.3389/fopht.2022.756689. eCollection 2022.
2
Artificial intelligence-assisted diagnosis of ocular surface diseases.人工智能辅助诊断眼表疾病。
Front Cell Dev Biol. 2023 Feb 17;11:1133680. doi: 10.3389/fcell.2023.1133680. eCollection 2023.
3
Grand Challenges for Artificial Intelligence in Molecular Medicine.分子医学中人工智能面临的重大挑战。
Front Mol Med. 2021 Jul 22;1:734659. doi: 10.3389/fmmed.2021.734659. eCollection 2021.
4
Applying artificial intelligence in the microbiome for gastrointestinal diseases: A review.应用人工智能于胃肠道疾病的微生物组学研究：综述。
J Gastroenterol Hepatol. 2021 Apr;36(4):832-840. doi: 10.1111/jgh.15503.
5
Common Pitfalls and Recommendations for Grand Challenges in Medical Artificial Intelligence.医学人工智能大挑战中的常见陷阱和建议。
Eur Urol Focus. 2021 Jul;7(4):710-712. doi: 10.1016/j.euf.2021.05.008. Epub 2021 Jun 11.
6
Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.精准精神病学应用中的药物基因组学：人工智能和机器学习方法。
Int J Mol Sci. 2020 Feb 1;21(3):969. doi: 10.3390/ijms21030969.
7
Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.利用人工智能、机器学习和组学重新思考药物重定位和开发。
OMICS. 2019 Nov;23(11):539-548. doi: 10.1089/omi.2019.0151. Epub 2019 Oct 25.
8
An overview of artificial intelligence in diabetic retinopathy and other ocular diseases.人工智能在糖尿病视网膜病变和其他眼部疾病中的应用概述。
Front Public Health. 2022 Oct 28;10:971943. doi: 10.3389/fpubh.2022.971943. eCollection 2022.
9
Machine learning meets omics: applications and perspectives.机器学习与组学的融合：应用与展望。
Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab460.
10
Advances in artificial intelligence applications for ocular surface diseases diagnosis.人工智能在眼表疾病诊断中的应用进展。
Front Cell Dev Biol. 2022 Dec 20;10:1107689. doi: 10.3389/fcell.2022.1107689. eCollection 2022.

引用本文的文献

1
Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases.释放 CRISPR 多重编辑的潜力：利用 Cas12 和 Cas13 精确调控眼部疾病相关基因。
Vision Res. 2023 Dec;213:108317. doi: 10.1016/j.visres.2023.108317. Epub 2023 Sep 16.
2
Taurine: a promising nutraceutic in the prevention of retinal degeneration.牛磺酸：一种预防视网膜变性的有前景的营养保健品。
Neural Regen Res. 2024 Mar;19(3):606-610. doi: 10.4103/1673-5374.380820.
3
Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature.细胞外囊泡作为炎症性眼病诊治的新领域：文献综述。
Front Immunol. 2023 Mar 9;14:1097456. doi: 10.3389/fimmu.2023.1097456. eCollection 2023.
4
Microemulsions as Lipid Nanosystems Loaded into Thermoresponsive In Situ Microgels for Local Ocular Delivery of Prednisolone.作为脂质纳米系统的微乳剂负载于热敏原位微凝胶中用于泼尼松龙的局部眼部给药
Pharmaceutics. 2022 Sep 19;14(9):1975. doi: 10.3390/pharmaceutics14091975.
5
Resolution of Inflammation in Retinal Disorders: Briefly the State.视网膜病变中的炎症消退：简要概述。
Int J Mol Sci. 2022 Apr 19;23(9):4501. doi: 10.3390/ijms23094501.

本文引用的文献

1
CD4 T-Cell Plasticity in Non-Infectious Retinal Inflammatory Disease.CD4 T 细胞在非传染性视网膜炎症性疾病中的可塑性。
Int J Mol Sci. 2021 Sep 3;22(17):9584. doi: 10.3390/ijms22179584.
2
Retinal Pigment Epithelial Cells Express Antimicrobial Peptide Lysozyme - A Novel Mechanism of Innate Immune Defense of the Blood-Retina Barrier.视网膜色素上皮细胞表达抗菌肽溶菌酶-血视网膜屏障固有免疫防御的新机制。
Invest Ophthalmol Vis Sci. 2021 Jun 1;62(7):21. doi: 10.1167/iovs.62.7.21.
3
Uveitis: Molecular Pathogenesis and Emerging Therapies.葡萄膜炎：分子发病机制与新兴疗法。
Front Immunol. 2021 Apr 30;12:623725. doi: 10.3389/fimmu.2021.623725. eCollection 2021.
4
Identification of an intraocular microbiota.眼内微生物群的鉴定。
Cell Discov. 2021 Mar 9;7(1):13. doi: 10.1038/s41421-021-00245-6.
5
Immune Privilege: The Microbiome and Uveitis.免疫赦免：微生物群与葡萄膜炎
Front Immunol. 2021 Jan 25;11:608377. doi: 10.3389/fimmu.2020.608377. eCollection 2020.
6
Elevated gut microbiome abundance of is associated with reduced visceral adipose tissue and healthier metabolic profile in Italian elderly.意大利老年人内脏脂肪组织减少和代谢特征更健康与肠道微生物丰富度升高有关。
Gut Microbes. 2021 Jan-Dec;13(1):1-19. doi: 10.1080/19490976.2021.1880221.
7
Ocular Microbiota and Intraocular Inflammation.眼部微生物群与眼内炎症
Front Immunol. 2020 Dec 23;11:609765. doi: 10.3389/fimmu.2020.609765. eCollection 2020.
8
Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.用FoxP3 +抗原致敏调节性T细胞治疗可阻止葡萄膜炎自发模型中的进行性视网膜损伤。
Front Immunol. 2020 Sep 4;11:2071. doi: 10.3389/fimmu.2020.02071. eCollection 2020.
9
Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: A claims-based analysis.美国传染性葡萄膜炎和巩膜炎的发病率、患病率和危险因素：一项基于索赔的分析。
PLoS One. 2020 Aug 25;15(8):e0237995. doi: 10.1371/journal.pone.0237995. eCollection 2020.
10
New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery.靶向炎症消退的新进展：对专门促消退介质G蛋白偶联受体药物发现的启示
ACS Pharmacol Transl Sci. 2020 Jan 20;3(1):88-106. doi: 10.1021/acsptsci.9b00075. eCollection 2020 Feb 14.